SlideShare a Scribd company logo
1. Inclusion criteria: The trial used an “all-comers” design.
2. Exclusion criteria
• Previous intervention
• Acute myocardial infarction
• Concomitant surgery.
Patients meeting either of the first two exclusion criteria were, according to the trial design, excluded
without consultation of the local interventional cardiologist and cardiac surgeon.
The need for concomitant surgery was discussed with the local interventional cardiologist and cardiac
surgeon.
Data for patients who were assigned to one treatment but underwent the other and for those who did
not undergo either revascularization procedure were analyzed in an intention-to-treat manner.
Registries Objective
• Patients were identified who were not candidates for randomization
based on clinical or anatomical characteristics and formed the basis
for the registry experience:
• Who were not candidates for CABG (inoperable patients)
• Who were not candidates for PCI (technically not feasible)
Reasons for Registry Allocation
PCI Registry- CABG ineligible due to:
• Co-morbidities (70.7%)
• No graft material (9.1%)
• Small or poor quality of distal
vessel (1.5%)
• Patient refused CABG (5.6%)
• Other (13.1%)
CABG Registry- PCI ineligible due to:
• Complex anatomy (70.9%)
• Untreatable CTO (22.0%)
• Unable to take anti-platelet medications (0.9%)
• Patient refused PCI (0.5%) Other (5.7%)
PRIMARY END POINT
• The primary clinical end point was a composite of major adverse cardiac and
cerebrovascular events (i.e., death from any cause, stroke, myocardial infarction, or
repeat revascularization) throughout the 12-month period after randomization.
• An independent clinical events committee (including cardiologists, cardiac surgeons, and
a neurologist;)
• Adjudicated all primary clinical end points, staged procedures, and cases in which the
sternum was reopened.
BACKGROUND 1234.pptx
BACKGROUND 1234.pptx
BACKGROUND 1234.pptx

More Related Content

Similar to BACKGROUND 1234.pptx

Randomized trial of_stents_versus
Randomized trial of_stents_versusRandomized trial of_stents_versus
Randomized trial of_stents_versus
GOPAL GHOSH
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
rajasekar nagarajan
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
Bhaswat Chakraborty
 
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptxRevascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
SpandanaRallapalli
 
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MIFFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
Shivani Rao
 
Protocol and thesis progress submission report
Protocol and thesis progress submission reportProtocol and thesis progress submission report
Protocol and thesis progress submission report
NavamDhiman1
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentation
STARSurg
 
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
GOPAL GHOSH
 
Cranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal ClubCranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal Club
MQ_Library
 
Renal Function After Off-Pump CABG: Journal Club
Renal Function After Off-Pump CABG: Journal ClubRenal Function After Off-Pump CABG: Journal Club
Renal Function After Off-Pump CABG: Journal Club
Wisit Cheungpasitporn
 
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
AnjalaNizam
 
17 aimradial2016 fri S Goel
17 aimradial2016 fri S Goel17 aimradial2016 fri S Goel
Hybrid coronary revascularization
Hybrid coronary revascularizationHybrid coronary revascularization
Hybrid coronary revascularization
rahatul quadir
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
htpplqzyafxxsptfln
 
Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -final
dwestenberger
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Claudio Melloni
 
CTO vs Medical management
CTO vs Medical managementCTO vs Medical management
CTO vs Medical management
Pavan Rasalkar
 
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
kazi alam nowaz
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
Hossam atef
 
Next-Generation Sequencing Analysis in VSClinical
Next-Generation Sequencing Analysis in VSClinicalNext-Generation Sequencing Analysis in VSClinical
Next-Generation Sequencing Analysis in VSClinical
Golden Helix
 

Similar to BACKGROUND 1234.pptx (20)

Randomized trial of_stents_versus
Randomized trial of_stents_versusRandomized trial of_stents_versus
Randomized trial of_stents_versus
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptxRevascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
 
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MIFFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
 
Protocol and thesis progress submission report
Protocol and thesis progress submission reportProtocol and thesis progress submission report
Protocol and thesis progress submission report
 
Star surg uk presentation
Star surg uk presentationStar surg uk presentation
Star surg uk presentation
 
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
 
Cranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal ClubCranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal Club
 
Renal Function After Off-Pump CABG: Journal Club
Renal Function After Off-Pump CABG: Journal ClubRenal Function After Off-Pump CABG: Journal Club
Renal Function After Off-Pump CABG: Journal Club
 
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
DMC Journal Club April 2022: Effects of Dexmedetomidine on Surgery for Type A...
 
17 aimradial2016 fri S Goel
17 aimradial2016 fri S Goel17 aimradial2016 fri S Goel
17 aimradial2016 fri S Goel
 
Hybrid coronary revascularization
Hybrid coronary revascularizationHybrid coronary revascularization
Hybrid coronary revascularization
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
 
Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -final
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
 
CTO vs Medical management
CTO vs Medical managementCTO vs Medical management
CTO vs Medical management
 
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
Perioperative cardiovascular assessment of patients undergoing noncardiac sur...
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
 
Next-Generation Sequencing Analysis in VSClinical
Next-Generation Sequencing Analysis in VSClinicalNext-Generation Sequencing Analysis in VSClinical
Next-Generation Sequencing Analysis in VSClinical
 

More from varshithkumar4

Presentation1111.pptx
Presentation1111.pptxPresentation1111.pptx
Presentation1111.pptx
varshithkumar4
 
update 11.pptx
update 11.pptxupdate 11.pptx
update 11.pptx
varshithkumar4
 
Presentation2.pptx
Presentation2.pptxPresentation2.pptx
Presentation2.pptx
varshithkumar4
 
hhhh.pptx
hhhh.pptxhhhh.pptx
hhhh.pptx
varshithkumar4
 
Presentation4.pptx
Presentation4.pptxPresentation4.pptx
Presentation4.pptx
varshithkumar4
 
P3.pptx
P3.pptxP3.pptx
P2.pptx
P2.pptxP2.pptx
Presentation5.pptx
Presentation5.pptxPresentation5.pptx
Presentation5.pptx
varshithkumar4
 
Effects of Sympathetic Stimulation 1.pptx
Effects of Sympathetic Stimulation 1.pptxEffects of Sympathetic Stimulation 1.pptx
Effects of Sympathetic Stimulation 1.pptx
varshithkumar4
 
FREEDOM Trial.pptx
FREEDOM Trial.pptxFREEDOM Trial.pptx
FREEDOM Trial.pptx
varshithkumar4
 
Presentation 4123.pptx
Presentation 4123.pptxPresentation 4123.pptx
Presentation 4123.pptx
varshithkumar4
 
Background 123.pptx
Background 123.pptxBackground 123.pptx
Background 123.pptx
varshithkumar4
 
Presentation334545.pptx
Presentation334545.pptxPresentation334545.pptx
Presentation334545.pptx
varshithkumar4
 
CARDIOLOGY SPOTTER 1111111.pptx
CARDIOLOGY SPOTTER 1111111.pptxCARDIOLOGY SPOTTER 1111111.pptx
CARDIOLOGY SPOTTER 1111111.pptx
varshithkumar4
 
answer.pptx
answer.pptxanswer.pptx
answer.pptx
varshithkumar4
 
qqq.pptx
qqq.pptxqqq.pptx
qqq.pptx
varshithkumar4
 
SYNTAX TRIAL.pptx
SYNTAX TRIAL.pptxSYNTAX TRIAL.pptx
SYNTAX TRIAL.pptx
varshithkumar4
 
JVP AND WAVEFORMS.ppt
JVP AND WAVEFORMS.pptJVP AND WAVEFORMS.ppt
JVP AND WAVEFORMS.ppt
varshithkumar4
 
SUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptxSUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptx
varshithkumar4
 
case presentation.pptx
case presentation.pptxcase presentation.pptx
case presentation.pptx
varshithkumar4
 

More from varshithkumar4 (20)

Presentation1111.pptx
Presentation1111.pptxPresentation1111.pptx
Presentation1111.pptx
 
update 11.pptx
update 11.pptxupdate 11.pptx
update 11.pptx
 
Presentation2.pptx
Presentation2.pptxPresentation2.pptx
Presentation2.pptx
 
hhhh.pptx
hhhh.pptxhhhh.pptx
hhhh.pptx
 
Presentation4.pptx
Presentation4.pptxPresentation4.pptx
Presentation4.pptx
 
P3.pptx
P3.pptxP3.pptx
P3.pptx
 
P2.pptx
P2.pptxP2.pptx
P2.pptx
 
Presentation5.pptx
Presentation5.pptxPresentation5.pptx
Presentation5.pptx
 
Effects of Sympathetic Stimulation 1.pptx
Effects of Sympathetic Stimulation 1.pptxEffects of Sympathetic Stimulation 1.pptx
Effects of Sympathetic Stimulation 1.pptx
 
FREEDOM Trial.pptx
FREEDOM Trial.pptxFREEDOM Trial.pptx
FREEDOM Trial.pptx
 
Presentation 4123.pptx
Presentation 4123.pptxPresentation 4123.pptx
Presentation 4123.pptx
 
Background 123.pptx
Background 123.pptxBackground 123.pptx
Background 123.pptx
 
Presentation334545.pptx
Presentation334545.pptxPresentation334545.pptx
Presentation334545.pptx
 
CARDIOLOGY SPOTTER 1111111.pptx
CARDIOLOGY SPOTTER 1111111.pptxCARDIOLOGY SPOTTER 1111111.pptx
CARDIOLOGY SPOTTER 1111111.pptx
 
answer.pptx
answer.pptxanswer.pptx
answer.pptx
 
qqq.pptx
qqq.pptxqqq.pptx
qqq.pptx
 
SYNTAX TRIAL.pptx
SYNTAX TRIAL.pptxSYNTAX TRIAL.pptx
SYNTAX TRIAL.pptx
 
JVP AND WAVEFORMS.ppt
JVP AND WAVEFORMS.pptJVP AND WAVEFORMS.ppt
JVP AND WAVEFORMS.ppt
 
SUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptxSUDDEN CARDIAC DEATH.pptx
SUDDEN CARDIAC DEATH.pptx
 
case presentation.pptx
case presentation.pptxcase presentation.pptx
case presentation.pptx
 

Recently uploaded

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 

Recently uploaded (20)

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 

BACKGROUND 1234.pptx

  • 1. 1. Inclusion criteria: The trial used an “all-comers” design. 2. Exclusion criteria • Previous intervention • Acute myocardial infarction • Concomitant surgery. Patients meeting either of the first two exclusion criteria were, according to the trial design, excluded without consultation of the local interventional cardiologist and cardiac surgeon. The need for concomitant surgery was discussed with the local interventional cardiologist and cardiac surgeon. Data for patients who were assigned to one treatment but underwent the other and for those who did not undergo either revascularization procedure were analyzed in an intention-to-treat manner.
  • 2. Registries Objective • Patients were identified who were not candidates for randomization based on clinical or anatomical characteristics and formed the basis for the registry experience: • Who were not candidates for CABG (inoperable patients) • Who were not candidates for PCI (technically not feasible)
  • 3. Reasons for Registry Allocation PCI Registry- CABG ineligible due to: • Co-morbidities (70.7%) • No graft material (9.1%) • Small or poor quality of distal vessel (1.5%) • Patient refused CABG (5.6%) • Other (13.1%) CABG Registry- PCI ineligible due to: • Complex anatomy (70.9%) • Untreatable CTO (22.0%) • Unable to take anti-platelet medications (0.9%) • Patient refused PCI (0.5%) Other (5.7%)
  • 4. PRIMARY END POINT • The primary clinical end point was a composite of major adverse cardiac and cerebrovascular events (i.e., death from any cause, stroke, myocardial infarction, or repeat revascularization) throughout the 12-month period after randomization. • An independent clinical events committee (including cardiologists, cardiac surgeons, and a neurologist;) • Adjudicated all primary clinical end points, staged procedures, and cases in which the sternum was reopened.